User:Afounamohsen

(آل عافون)(عفونة): تتركز العائلة في محافظة الشرقية (مسقط رأسي ومحل إقامة العائلة) والإسكندرية والقاهرة والجيزة
... وللعلم هناك إمتدادللعائلة في الأردن وفلسطين والبحرين والإمارات ... مع بعض التحريف في اللهجة ... 

معلومة خاصة: أصل الإسم مادة (العفو).. وكانت القبيلة العربية مشتهرة بالعفو فلقبوا ب (آل عافون) ... وأثناء الحكم العثماني كان الألف يكتب مداً كما في القرآن الكريم فكانت حتي حكم

الملكية هكذا (آلعفون) مع وضع مد بعد العين ... وبعد الستينات توقف إستعمال كلمة (آل أو أهل) فأصبحت تُكتب هكذا (عفونة)
بعدما نالها التحريف في النقل من السجلات بالطريقة اليدوية ... واسقرت علي هذا ..

[MOHSEN I. AFOUNA] PROFILE Highly motivated scientist (teacher, researcher) with expertise in development of topical, ocular and transdermal drug delivery systems. Experienced in development of non-clinical methodologies to assess the topical efficacy of various antiviral agents. Outstanding background in pharmaceutical sciences, development and management of scientific research projects combined with fluency in English and Arabic. Author of several recent articles, review articles and chapter in textbook regarding oral, ocular, topical, transdermal, chirality and biopharmaceutics. Excellent written and oral communication skills with supervisory and teaching experience. Driven pharmaceutical scientist, love to work in a dynamic teaching, research and development environment.

EDUCATION 1998 Ph.D. (Pharmaceutical Sciences), Pharmaceutics in a joint supervision program between the University of Al-Azhar (Egypt) and the University of Utah (SLC, UT, USA), Department of Pharmaceutics and Pharmaceutical Sciences.

1995 M. S. Pharmaceutical Sciences (Pharmaceutics), College of Pharmacy, Al-Azhar University. Nasr City, Cairo, Egypt.

1987 B. S., Pharmacy, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.

EXPERIENCES 1. Professor of Pharmaceutics and Clinical Pharmaceutics, Department Pharmaceutics and Clinical Pharmaceutics, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. 4/2006- present.

2. Associate Professor of Pharmaceutics and Clinical Pharmaceutics, Department of Pharmaceutics and Department of Clinical Pharmacy, College of Pharmacy, King Abdul Aziz University, Jeddah, KSA, 2006-to-9/2010

3. Assistant Professor of Pharmaceutics and Clinical Pharmaceutics, Department of Pharmaceutics and Department of Clinical Pharmacy, College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.10/2003-4/2006.

4. Assistant Professor of Pharmaceutics and Clinical Pharmaceutics, Department Pharmaceutics and Clinical Pharmaceutics, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. 5/2003- 10/2003.

5. Research Scientist, Department of Pharmaceutical Sciences, University of Arkansas of Medical Sciences (UAMS), College of Pharmacy, Little Rock, AR 72205, USA, 2001-2003.

6. Assistant Professor of Pharmaceutics and Clinical Pharmaceutics, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. 12/1998-March 2002.

7. Ph.D. studies with Distinguished Professor Dr. William I. Higuchi and Professor Abdel H. Ghanem, Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah, Salt Lack City, UT, USA. 1996-1998.

8. Assistant Lecturer, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. 1995-1996.

9. Teaching Assistant, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. 4/1989-10/1995.

10. Pharmacist in the Egyptian Army Forces “mandatory service”, 1/1988-4/1989.

11. Community Pharmacist in the private sector pharmacies, 7/1987 to 1/1988.

SELECTED PUBLICATIONS

1. Mohamed A. Amin, Alaa zaky, Asmaa Elbakry, Gamal Zayed, Amal Hussein, Mohsen I. Afouna. Preparation and Characterization of Nanosuspensions to Improve the In Vitro Dissolution Rate and In Vivo Efficacy of Poorly Soluble Drug Using Nimesulide as a Model Drug. (In writing).

2. Amal K. Hussein, Shahira F. El-Menshawe, Mohsen I. Afouna. Improved In-vitro Dissolution and In-vivo Oral Bioavailability of Silymarin, from Liquid-Filled Hard Gelatin Capsules of Semisolid Dispersion Using Gelucire 44/14 as a Carrier, Pharmazie 67: 1–6, doi: 10.1691/ph.2012.1109, (2012).

3. Mohsen I. Afouna. Influence of Different Chiral Terpinen-4-ol Enhancer Concentrations upon Solubility and Percutaneous Transport of Timolol Maleate Individual Isomers and Racemate Using Hairless Mice Skin: A Comparative Study. Egyp. J. Sci. and Biotech., 3, 145-161, (2011).

4. Amal K. Hussein, Mohamed A. Ibrahim, Mohamed A. Amin, Osama A. A. Ahmed, Mohsen I. Afouna. Improved In Vitro Dissolution Parameters and In Vivo Hypolipidimic Efficiency of Atorvastatin Calcium through the Formation of Hydrophilic Inclusion Complex with Cyclodextrins. Journal of Drug Development Research., 72, 1-12, (2011).

5. Mohsen I. Afouna, Ashraf A. Naim, Ala'a Khedr and Adnan El-Marzoqi. Influence of Various Concentrations of Terpene-4-ol enhancer and Carbopol-934 Mucoadhesive upon the In Vitro Ocular Transport and the In Vivo Intraocular Pressure Lowering Effects of Dorzolamide Ophthalmic Formulations Using Albino Rabbits, Journal of Pharmaceutical Sciences; 99(1):119-27, (2010).

6. Mohsen I. Afouna, Ala'a Khedr and Adnan El-Marzoqi. Effects of (-)-Carveol and HPMC upon the In Vitro Ocular Transport and the In Vivo Intraocular Pressure Lowering Effects of Dorzolamide Formulations in Normotensive New Zealand Rabbits. Journal of Drug Development Research, 70(3): 191-198 (2009).

7. Mohsen I. Afouna, Ala'a Khedr and Adnan El-Marzoqi. Effects of Various Concentrations of (-)-Carveol and HPMC upon the In Vitro Ocular Transport and the In Vivo Intraocular Pressure Lowering Effects of Dorzolamide Formulations in Normotensive New Zealand Rabbits. Journal of Drug Development Research,; 70 (3) (2009).

8. A. Zaghloul, E. Taha, Mohsen I. Afouna, I. Khattab1, S. Nazzal. Ex vivo mucoadhesion and in vivo bioavailability assessment and correlation of ketoprofen tablet dosage forms containing bioadhesives. Pharmazie 62: 346–350 (2007). 9. Ibrahim S Khattab, Abdel-Azim A Zaghloul, Mohsen I. Afouna. Studies on the development of rapidly disintegrating hyoscine butylbromide tablets. Drug Discov Ther 1(1):61-64 (2007). 10. Mohsen I. Afouna. Enantioselective Transport of Chiral -Blocker Timolol Maleate through Hairless Mice Skin upon Using Various Concentrations of Chiral Terpene Enhancer (-)– Carveol. Egyptian Journal of Biomedical Sciences, 18, 163-179, (2005). 11. Mohsen I. Afouna, Ibrahim S. Khattab and Indra K. Reddy. Preparation and Characterization of Demeclocycline Liposomal Formulations and Assessment of their Intra-ocular Pressure Lowering Effects using rabbit model. Journal of Toxicology-Cutaneous and Ocular Toxicology, 24 (2), 111-124, (2005). 12. Touitou Elka, Biana Godin, Kommuru R. Thirumala, Mohsen I. Afouna, Reddy K. Indra, Skin Transport of Optically Active Stereoisomers, In: Chirality in Drug Design and Development, Reddy K. Reddy, Reza Mehvar (Editors), Marcel Dekker, Inc., New York, March, (2004).

13. Hutak CM, Kavanagh ME, Mohsen I. Afouna, Khan M. A. and Reddy I. K. Using of SIRC Rabbit Corneal Cell Lines Grown on Polycarbonate- or Polyester-Based Filters for the in Vitro Corneal Transport//Toxicity Screening Using Pilocarpine with and without Benzalkonium Chloride. Journal of Toxicology-Cutaneous and Ocular Toxicology, 22 (1,2), 101-114, (2003).

14. Mohsen I. Afouna, Fincher T. K., Khan M. A. and Reddy I. K. Percutaneous Permeation of Optically Active and Racemic Mixtures of Chiral Drugs and Prediction of their Flux Ratios Using Thermal Data: A Pharmaceutical Perspective. Chirality. 15(5):456-65. Review (2003).

15. Mohsen I. Afouna, Fincher T. K., Abdel Azim A. Zaghloul, and Reddy I. K. Effect of Azone upon the In vivo Antiviral Efficacy of Cidofovir or Acyclovir Topical Formulations against Cutaneous HSV-1 Infections and Its Correlation with Skin Target Site Free Drug Concentration Using Hairless Mice. International Journal of Pharmaceutics, 253 (1-2), 159 – 168, (2003).

16. Mohsen I. Afouna, Influence of Various Azone Concentrations upon Skin Target Site Free Drug Concentration (C*) of Bromovinyldeoxyuridine (BVDU) and Acyclovir (ACV) Formulations Using Hairless Mice: A Comparative Study. Az. J. Pharmaceutical Sciences., 28: 26-37, (2001).

17. Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy, H. Influence of the Treatment Protocol upon the In-Vivo Efficacy of Cidofovir (HPMPC) and Acyclovir (ACV) Formulations in Topical Treatment of Cutaneous HSV-1 Infections in Hairless Mice, Journal of Pharmaceutical Sciences, 88(5): 530-534 (1999).

18. Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., and DeClercq, E., and El-Shattawy, H. Influence of when Therapy is Initiated upon the in Vivo Efficacy of HPMPC in Treatment of Cutaneous HSV-1 Infections in Hairless Mice. Journal of Controlled Release, Proceeding, (5): 593-596 (1998).

19. Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy, H. Assessment of Correlation between Skin Target Site Free Drug Concentration and the In-Vivo Topical Efficacy in Hairless Mice for (E)-5-(2-Bromovinyl)-2-Deoxyuridine and Acyclovir Formulations. Journal of Pharmaceutical Sciences, 87(8): 917-921 (1998).

20. Mehta, S. C., Mohsen I. Afouna, Ghanem, A-H., Higuchi, W. I. and Kern, E. R. Relationship of Skin Target Site Free Drug Concentration (C*) to the In-Vivo Efficacy: An Extensive Evaluation of the Predictive Value of the C* Concept Using Acyclovir as a Model Drug. Journal of Pharmaceutical Sciences, 86(7): 797-801 (1997).

21. Samir C. Mehta, Mohsen I. Afouna, Abdel-Halim Ghanem, William I. Higuchi, Earl R. Kern and Hamed El-Shattawy. The relationship of basal cell layer drug concentration (C*) to the antiviral efficacy: A rigorous evaluation of the C* concept for predicting the entire range of topical efficacy of acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice, Antiviral Research, 34, P-80 (1997).

22. Mohsen I. Afouna, Ph.D. Dissertation, Optimization of the Availability of Antiviral Agent Using Topical Application in a joint supervision program between the University of Al-Azhar (Egypt) and the University of Utah, SLC, UT (USA), (1998).

23. Mohsen I. Afouna, Master’s Thesis, Pharmaceutical Studies on the Availability of Enalapril Maleate, Al-Azhar University, (1995).

PUBLISHED CHAPTERS 1. Touitou Elka, Biana Godin, Kommuru R. Thirumala, Mohsen I. Afouna, Reddy K. Indra. Skin Transport of Optically Active Stereoisomers, In: “Chirality in Drug Design and Development”. Reddy K. Reddy, Reza Mehvar (Editors), Marcel Dekker, Inc., New York, March, (2004). SELF-PUBLISHED BOOKS FOR PHARMACY STUDENTS:

1. Mohsen I. Afouna. “Introduction to the Pharmaceutical Dosage Forms”

2. Mohsen I. Afouna. “Sterile Dosage Forms: Preparation and Clinical Applications”

3. Mohsen I. Afouna. “Basics of Physical Pharmacy"

4. Mohsen I. Afouna. “Biopharmaceutical and Clinical Pharmacokinetics"

ABSTRACTS PRESENTED IN INTER/NATIONAL MEETINGS & WORKSHOPS

1. Mohamed A. Amin, Alaa zaky, Asmaa Elbakry, Gamal Zayed, Amal Hussein, Mohsen I. Afouna. Preparation and Characterization of Nanosuspensions to Improve the In Vitro Dissolution Rate and In Vivo Efficacy of Poorly Soluble Drug Using Nimesulide as a Model Drug. The AAPS Annual Meeting, Chicago, USA, Oct. 2012.

2. Amal K. Hussein, Shahira F. El-Menshawe, Mohsen I. Afouna. Improved In-vitro Dissolution and In-vivo Oral Bioavailability of Silymarin, from Liquid-Filled Hard Gelatin Capsules of Semisolid Dispersion Using Gelucire 44/14 as a Carrier. The AAPS Annual Meeting, Washington DC, USA, Oct. 2011.

3. Mohsen I. Afouna, Ala'a Khedr and Adnan El-Marzoqi. Influence of HPMC and (-)-Carveol upon the In Vitro Ocular Transport and the In Vivo Intraocular Pressure Lowering Effects of Dorzolamide Formulations Using New Zealand Rabbits. FIP Annual Meeting, Istanbul, Turkey, Sep. 2-9, 2009).

4. Mohsen I. Afouna, Ibrahim S. Khattab, Abdel-Azim A. Zaghloul, and Indra K. Reddy. Stereoselective Transport of Timolol Maleate across Hairless Mice Skin upon Using Different Concentrations of Chiral Terpinen-4-ol Enhancer. FIP Annual Meeting, Istanbul, Turkey, Sep. 2-9, 2009.

5. Mohsen I. Afouna, Ibrahim S. Khattab and Indra K. Reddy. Demeclocycline Liposomal Formulations: Preparation, Characterization and Assessment of their Intra-ocular Pressure Lowering Effects using rabbit model, The 9th International Pharmaceutical Sciences Meeting and Exposition, Dec. (2005).

6. Mohsen I. Afouna, [Bio]availability of Topical Formulations: From Ambiguous Definition to Lack of Generaliz[able] Approaches for Assessments. The 9th International Pharmaceutical Sciences Meeting and Exposition, Dec. (2005).

7. Training workshop in “Application of Software in the Design of Advanced Learning website (Web CT). Center of Development of Higher Education, King Abdul Aziz University, Jeddah, KSA. (2005).

8. Training workshop in “Effective Teaching Skills”. Center of Development of Higher Education, King Abdul Aziz University, Jeddah, KSA, (2005).

9. Training workshop in “Planning and Preparation of Multiple Choice Questions (MCQ) Exams. Center of Development of Higher Education, King Abdul Aziz University, Jeddah, KSA, (2005).

10. Mohsen I. Afouna, Ibrahim, E. A., Kassem, Fincher K. I. and Reddy K. I. Stability Characterization of Long-Acting Angiotensin Converting Enzyme Inhibitor; Enalapril Maleate Physical Mixtures with Selected Excipients Using Differential Scanning Calorimetry. The SRDG, Annual Meeting, Little Rock, AR, USA, May, 2002.

11. Mohsen I. Afouna, Ibrahim, E. A., Kassem, A., Fincher K. I. and Reddy K. I. Influence of Tablet Manufacturing Technique on the Physic-mechanical Characteristics, of Enalapril Maleate Tablets. The AAPS Annual Meeting, Toronto, Canada, Oct. 2002. 12. Fincher T. K., Mohsen I. Afouna, and Reddy I. K. Effect of the physicochemical characteristics upon the permeability of drug using chiral terpene enhancers. The AAPS Annual Meeting, Montreal, Canada, Oct. 2002.

13. T. K. Fincher, Mohsen. I. Afouna, I. K. Reddy. Effect of Thermodynamic Activity of Drugs and Chiral Terpene Permeation Enhancers upon the In-Vitro Flux of Selected Optically Active and Racemic Molecules across Hairless Mouse Skin. The AAPS Annual Meeting, Montreal, Canada, Oct. 2002.

14. Mohsen I. Afouna, Influence of Various Azone Concentrations upon Skin Target Site Free Drug Concentration (C*) of Bromovinyldeoxyuridine (BVDU) and Acyclovir (ACV) Formulations Using Hairless Mice: A Comparative Study. The AAPS Annual Meeting, Colorado, Denver, USA, Oct. 2001.

15. Mohsen I. Afouna, Ibrahim, E. A., Kassem, A and El-Shattawy, H Stability Characterization of Long-Acting Angiotensin Converting Enzyme Inhibitor; Enalapril Maleate Physical Mixtures with Selected Excipients Using Differential Scanning Calorimetry. The AAPS Annual Meeting, Colorado, Denver, USA, Oct. 2001.

16. EPS/AAPS/FIP workshop on the Bioequivalence Classification Systems, by the Egyptian Pharmacist Syndicate, Cairo, Egypt, Feb. (2000).

17. Mohsen I. Afouna, The in vivo Antiviral Efficacy of Cidofovir (HPMPC) and Acyclovir (ACV) Topical Formulations with or without Azone Against Cutaneous HSV-1 Infection in Hairless Mice Employing Different Treatment Protocols. 15th Annual Meeting of American Association of Pharmaceutical Scientists, Indianapolis, Indiana, USA, Oct. (2000).

18. Pharmex Consulting Group Workshop on Percutaneous Drug Absorption; Mechanisms-Methodology-Formulations Delivery-Toxicity, by Dr. Ghanem, A-H, and, Research Prof. of Pharmaceutics at the Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lack City, Utah, USA, March, (1999).

19. Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy, H. Assessment of Correlation between the Skin Target Site Free Drug Concentration (C*) and the In-Vivo Efficacy for Bromovinyldeoxyuridine (BVDU) and Acyclovir Formulations in the Treatment of Cutaneous HSV-1 Infections in Hairless Mice, the 11th International Conference on Antiviral Research (Oral Session), San Diego, California, USA, April (1998).

20. Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy, H. Absence of Correlation between C* Predictions and the In-Vivo Topical Antiviral Efficacy in Hairless Mice for Bromovinyldeoxyuridine (BVDU) Formulations. Twelfth Annual Meeting of American Association of Pharmaceutical Scientists, Boston, Massachusetts, USA, Nov. (1997).

21. Mehta, S. C., Mohsen I. Afouna, Ghanem, A-H., Higuchi, W. I., and Kern, E. R. The relationship of basal Cell Layer Drug Concentration (C*) to the Antiviral Efficacy: A Rigorous Evaluation of the C* Concept for Prediction of the Entire Range of Topical Efficacy of Acyclovir Formulations in the Treatment of Cutaneous HSV-1 Infections in Hairless Mice, The10th International Conference on Antiviral Research, Atlanta, Georgia, USA, April (1997).

22. Mehta, S. C., Mohsen I. Afouna, Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy, H. Absence of Correlation between C* Predictions and the In-Vivo Topical Antiviral Efficacy in Hairless Mice for Bromovinyldeoxyuridine (BVDU) Formulations. The 11th Annual Meeting of American Association of Pharmaceutical Scientists, Seattle, Washington State, USA, October (1996). o CO-INVESTIGATOR & APPLIED GRANT PROPOSALS 1. Grant-in-aid (SR 1.8 Million)/2-years for development of novel anti-diabetic drug delivery systems (PI), King Abdulaziz City for Sciences and Technology (KACST), King Abdulaziz University-Deanship or Scientific Research (KAU-DSR), Approved and on-going.

2. Grant-in-aid for Treatment of Prostatic Diseases Chair (Co-PI), KAU, (SR 3.00)/3-years.

3. Grant –in-aid for KAU-IRC, SR 110,800 for developing novel Dorzolamide ophthalmic solutions and gels for management glaucoma in KSA.

4. A grant-in-aid to Thera-tech Inc., $± 70,000 for “Developing a Non-Clinical Methodology to assess the topical efficacy of various Antiviral agents such as Acyclovir (ACV), Cidofovir (HPMPC ) and Bromovinyldeoxyuridine (BVDU).

o TEACHING COURSES & ACADEMIC ACTIVITIES

1. Physical Pharmacy including, State of matter, Thermodynamics, Electrolytes and Non-electrolytes, Drug Stability and Reaction Kinetics, Solubility, Drug diffusion, International Phenomenon, Colloids, and coarse dispersions).

2. Drug Delivery Systems and Pharmaceutical Dosage Forms including, ocular, topical & systemic liquid, semisolid, solid, sterile, and pressurized dosage forms.

3. Biopharmaceutics and Basic/Clinical Pharmacokinetics.

4. Pharmaceutical and Clinical Calculations. o COMMUNICATION/LEADERSHIP/TEAM WORK

1. Chairman of “Egyptian Pharmacists for Pharmaceutical Research”, an NGO responsible for wide varieties of noble goals serving the entire Egyptian community (In the Establishing Process).

2. Primary author/co-author of several publications in peer-reviewed journals (see list above).

3. Active participant in several research projects requiring collaboration with other laboratories/researchers during M.S, Ph.D. and Post-doctoral work.

4. Chief and founder of the “Unit of Quality Assurance and Academic Accreditation (UQAAA) “College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.

5. Chief and founder of the "Course Portfolio Committee”, College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.

6. Member of the “IT Unite & Committee”, College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.

7. Member of the “Libraries Committee”, College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.

8. Member of the “Continuing Pharmacy Education Committee (CPE)”. College of Pharmacy, King Abdul Aziz University, Jeddah, KSA.

9. Member of the “The Department of Pharmaceutics Council” College of Pharmacy, KAU, Jeddah, KSA.

10. Saudi Arabia National Radio, “Around the Scientific Research Table” program, 2008.

11. Teaching of different courses of pharmaceutical Sciences in the Department of Pharmaceutics, King Abdul Aziz University, Al-Azhar University, and Ain Shams University.

12. Member in the oral exam committee for many of the Colleges of Pharmacy in Egypt.

o HONORS & ACHIEVEMENTS

1. Ranked first in overall academic rating at the College of Pharmacy at Al-Azhar University during many years of the undergraduate pharmacy study.

2. Two-year scholarship for Ph.D. study at the University of Utah, College of Pharmacy.

3. Post-doctorate Fellowship (Research Scientist) from the School of Pharmacy at UAMS, LR, AR, USA.

4. R & D Consultant for various Egyptian and Saudi Pharmaceutical Co.

5. Two Prizes (Cash money and Honor Certificates) from KAU for outstanding research & publication (2011).

o JOURNAL REVIEWER 1. Journal of Pharmaceutical Sciences

2. Open Journal of Ophthalmology

3. Letter of Drug Development Research.

4. Letter in Drug Design and Discovery.

5. Drug Development and Industrial Pharmacy.

6. Journal of Pharmaceutical Health and Research.

7. King Abdulaziz University Medical Journal.

8. European Journal of Pharmacy Biopharmaceutics.

9. Pharmaceutical Research.

10. Many others

• MEMBERSHIP 1. American Association of Pharmaceutical Scientist.

2. Southern Region Discussion Group (SRDG).

3. Controlled Release Society, Inc.

4. American Association of College of Pharmacy (AACP).

5. American Association for Advancement of Science (AAAS).

6. Science Advisory Board (SAB).

7. Included in the Academic Keys Who's Who (2002, 2003 and 2008).

8. Included in the Academic Keys Who's Who in New York Health Sciences (2009).

9. Egyptian Pharmacist syndicate.

10. The International Society of Antiviral Research.

11. Saudi Council for Continuing Health Education.